Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
52 hedge funds and large institutions have $37.9M invested in Applied Genetic Technologies Corporation in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 10 closing their positions.
11% more capital invested
Capital invested by funds: $34.1M → $37.9M (+$3.77M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 55 → 52 (-3)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$516K |
| 2 |
JP Morgan Chase
New York
|
+$189K |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$111K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$100K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$67.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$228K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$183K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$175K |
| 4 |
FAM
Fred Alger Management
New York
|
-$146K |
| 5 |
BlackRock
New York
|
-$123K |
AGTC Hedge Fund Activity: Q4 2019 in Review
52 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2019, worth a combined $37.9M — up 11% from $34.1M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AGTC and 7 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 12 added.
The largest buyer was Renaissance Technologies, adding an estimated $516K. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $228K sold.
- 52 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2019, down from 55 in Q3 2019.
- Funds reported $37.9M of Applied Genetic Technologies Corporation stock for Q4 2019, up 11% quarter-over-quarter.
- 7 funds opened new Applied Genetic Technologies Corporation positions in Q4 2019 and 10 closed out, a net change of -3 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q4 2019 was Renaissance Technologies, an estimated $516K added.
- The largest Applied Genetic Technologies Corporation seller in Q4 2019 was D.E. Shaw & Co, an estimated $228K sold.
Based on aggregated 13F filings for Q4 2019.